Navigation Links
Zinc reduces morbidity due to diarrhea in HIV+ children

According to new research, published in November - December issue of the prestigious journal Lancet, zinc supplementation should be used as adjunct therapy for children with HIV-1 infection // , since it cuts the chance of diarrhea and pneumonia without risking deterioration of HIV infection.

Zinc deficiency is previously known to be associated with impaired immune function and an increased risk of infection. Diarrhea is one of the leading causes of death among children with HIV/AIDS as the compromised immunity make them vulnerable to stomach infections.

For the study, the researchers recruited 96 children with HIV-1 infection, aged between 6 months and five years, from Grey’s Hospital in Pietermaritzburg, South Africa. The children were randomly assigned to receive zinc supplements or placebo daily for 6 months.

Measurements of plasma HIV-1 viral load and the percentage of CD4+ T lymphocytes were established before, and 3, 6, and 9 months after the start of supplementation.

The researchers found that zinc supplementation did not result in an increase in blood HIV viral load. Children given zinc supplementation were less likely to get watery diarrhea than those given placebo.

Zinc is an essential trace element, which is important for growth, development, and immunity. However, prior to this study, there has been concern about the safety of supplements for HIV patients because the virus that causes AIDS also needs it to function and replicate.

Results from this study suggest zinc supplementation can be implemented without concern for adverse effects on HIV-1 replication.

The authors propose that in view of the safety and beneficial reductions in diarrhea and pneumonia morbidity, zinc supplementation should be used as adjunct therapy for children with HIV-1 infection, especially in resource-poor countries.


'"/>




Page: 1

Related medicine news :

1. Stress reduces your immunity- startling but true!!!!!
2. Thirty minutes of work up per day reduces the risk of Diabetes
3. Aspirin reduces deaths
4. Tomato Sauce reduces Cancer Risk- Study
5. Calcium reduces colon cancer risk
6. New pacemaker reduces risk of heart failure
7. Vitamin D reduces heart risk
8. Back exercises reduces Osteoporosis
9. Caffeine reduces infant blood flow
10. Radiation reduces cancer recurrence
11. Tamoxifen reduces breast cancer risk
Post Your Comments:
(Date:7/18/2008)...est weight loss yields significant health benefits...oalition -- a group of,experts on overweight and o...dia to reevaluate the way they report on weight lo...ed news coverage and editorial content that,leads ... dieters if they,lose an enormous amount of weight...
(Date:7/18/2008)...n Is Not What America Signed Up For, WASHINGTON, ... McCain,s,top economic advisor, Phil Gramm, echoed...s were "psychological" by saying Americans are in ... "nation of whiners." While McCain,distanced himse...ard as,McCain,s top economic adviser. Now, John Mc...
(Date:7/18/2008)... Behavior spanning the wide spectrum of the animal...rnational Behavioral Ecology Congress, hosted by t...n Aug. 10 -14, 2008, at Cornell University in Itha...e congress will feature plenary sessions on: , ...olutionary biology, Yale University, on "When Theo...
(Date:7/18/2008)...ren preventive antibiotics within one hour before ...sk for serious infections after the surgery, sugge...ugust issue of Pediatric Infectious Disease Journ...en who received antibiotics outside of the golden ...ely to develop serious infections at the surgery s...
Breaking Medicine News(10 mins):Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 3Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3Health News:Averting postsurgical infections in kids: Give antibiotics within hour before first incision 2
...for resistance to food allergy has been identified...s currently no way to treat food allergy and the ... avoid certain foods and make sure they have injec...led by Dr Claudio Nicoletti at the Institute of Fo...
...ficials of DelSite Biotechnologies, Inc., a wholly... said the company's novel powder-based vaccine de...les that delay influenza pandemic preparedness whi...tions for the Control of Influenza VI Conference" ...
...nsylvania, Shire plc announced today that it has s...A) to the U.S. Food and Drug Administration (FDA) ...the treatment of Attention Deficit Hyperactivity D...cation is subject to a 10-month FDA review period....
...of Wales has proposed that artists are important t...Wales to help create better environments for pati... for all new hospital that is going to come up in ...order to ensure that the patients morale is booste...
Other Medicine News:Health News:Potential Target for Allergy Therapy 2Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 2Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 3Health News:VYVANSE(TM) Drug for the Treatment of ADHD in Adults 2Health News:Art in Hospitals to Enhance Patient Care 2
(Date:7/16/2008)... INTERNATIONAL AIDS SOCIETY AND KAISER FAMILY FOU...RAGE OF CONFERENCE FOR FREE, MENLO PARK, Calif., ...,International AIDS Society (IAS) and the Kaiser F...ess to the XVII International AIDS Conference,(AID...ugust 2008. Kaiser --,an independent operating fou...
(Date:7/16/2008)...Expanded Collaboration Supports Pivotal Phase 2b C...dress an Underlying Cause of Cystic Fibrosis -, S...- PTC,Therapeutics, Inc. (PTC) and Cy..., the nonprofit affiliate of the Cystic Fibrosis F...sting collaboration to support development,of PTC1...
(Date:7/15/2008)... - Company Reports Favorable Phase 1 RX-33...re/ -- Rib-X Pharmaceuticals, Inc.,("Rib-X" or the...n the,discovery and development of novel antibioti...tions, today announced the initiation of a Phase,2...tic compound RX-3341 in,the treatment of complicat...
(Date:7/15/2008)... BOSTON, July 15 /-Scimitar Equity, ...Board: ADXS), entitled, "The New Generation of,Can...e at website: http://www.scimitarequity.com ., B...is developing,proprietary Listeria monocytogenes (...d by Dr. Yvonne Paterson, Professor of Microbiolog...
Breaking Medicine Technology:Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 2Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 3Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 4PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 2PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 3PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 4Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC 2High Fat Diet Can Disrupt Bodys Clock 5652 1High Fat Diet Can Disrupt Bodys Clock 5652 2AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 1AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 2Frontiers in Cancer Prevention Research 1128 1New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 1New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 2New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 3
...ined Improvements in Blood Glucose,Control and Pro...Newswire-FirstCall/ -- Amylin,Pharmaceuticals, Inc...s from a study that showed BYETTA(R) (exenatide) i...els and progressive weight,loss through three and ... associated with improvements in cardiovascular ri...
...INESS WIRE)--June 25, 2007--Gilead,Sciences, Inc. ...ase III clinical trial evaluating the company,s on...oxil fumarate or tenofovir,DF) 300 mg as a potenti...nfection, met its primary efficacy endpoint. The d...y,s once-daily antiviral,drug Hepsera(R) (adefovir...
Other Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: